vs

Side-by-side financial comparison of ICON PLC (ICLR) and Organon & Co. (OGN). Click either name above to swap in a different company.

ICON PLC is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.4× Organon & Co.). ICON PLC runs the higher net margin — 0.1% vs -13.6%, a 13.7% gap on every dollar of revenue. On growth, ICON PLC posted the faster year-over-year revenue change (0.6% vs -5.3%). ICON PLC produced more free cash flow last quarter ($333.9M vs $96.0M). Over the past eight quarters, ICON PLC's revenue compounded faster (0.6% CAGR vs -3.6%).

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

ICLR vs OGN — Head-to-Head

Bigger by revenue
ICLR
ICLR
1.4× larger
ICLR
$2.0B
$1.5B
OGN
Growing faster (revenue YoY)
ICLR
ICLR
+6.0% gap
ICLR
0.6%
-5.3%
OGN
Higher net margin
ICLR
ICLR
13.7% more per $
ICLR
0.1%
-13.6%
OGN
More free cash flow
ICLR
ICLR
$237.9M more FCF
ICLR
$333.9M
$96.0M
OGN
Faster 2-yr revenue CAGR
ICLR
ICLR
Annualised
ICLR
0.6%
-3.6%
OGN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ICLR
ICLR
OGN
OGN
Revenue
$2.0B
$1.5B
Net Profit
$2.4M
$-205.0M
Gross Margin
49.2%
Operating Margin
4.2%
-9.8%
Net Margin
0.1%
-13.6%
Revenue YoY
0.6%
-5.3%
Net Profit YoY
-98.8%
-288.1%
EPS (diluted)
$0.03
$-0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICLR
ICLR
OGN
OGN
Q4 25
$1.5B
Q3 25
$2.0B
$1.6B
Q2 25
$2.0B
$1.6B
Q1 25
$2.0B
$1.5B
Q4 24
$1.6B
Q3 24
$2.0B
$1.6B
Q2 24
$2.1B
$1.6B
Q1 24
$2.1B
$1.6B
Net Profit
ICLR
ICLR
OGN
OGN
Q4 25
$-205.0M
Q3 25
$2.4M
$160.0M
Q2 25
$183.0M
$145.0M
Q1 25
$154.2M
$87.0M
Q4 24
$109.0M
Q3 24
$197.1M
$359.0M
Q2 24
$146.9M
$195.0M
Q1 24
$187.4M
$201.0M
Gross Margin
ICLR
ICLR
OGN
OGN
Q4 25
49.2%
Q3 25
53.5%
Q2 25
54.8%
Q1 25
55.6%
Q4 24
56.3%
Q3 24
58.3%
Q2 24
58.4%
Q1 24
59.0%
Operating Margin
ICLR
ICLR
OGN
OGN
Q4 25
-9.8%
Q3 25
4.2%
15.2%
Q2 25
10.4%
14.4%
Q1 25
11.0%
6.7%
Q4 24
8.1%
Q3 24
14.1%
13.1%
Q2 24
10.8%
14.6%
Q1 24
13.7%
14.5%
Net Margin
ICLR
ICLR
OGN
OGN
Q4 25
-13.6%
Q3 25
0.1%
10.0%
Q2 25
9.1%
9.1%
Q1 25
7.7%
5.8%
Q4 24
6.8%
Q3 24
9.7%
22.7%
Q2 24
6.9%
12.1%
Q1 24
9.0%
12.4%
EPS (diluted)
ICLR
ICLR
OGN
OGN
Q4 25
$-0.78
Q3 25
$0.03
$0.61
Q2 25
$2.30
$0.56
Q1 25
$1.90
$0.33
Q4 24
$0.42
Q3 24
$2.36
$1.38
Q2 24
$1.76
$0.75
Q1 24
$2.25
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICLR
ICLR
OGN
OGN
Cash + ST InvestmentsLiquidity on hand
$468.9M
$574.0M
Total DebtLower is stronger
$8.6B
Stockholders' EquityBook value
$9.3B
$752.0M
Total Assets
$16.5B
$12.9B
Debt / EquityLower = less leverage
11.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICLR
ICLR
OGN
OGN
Q4 25
$574.0M
Q3 25
$468.9M
$672.0M
Q2 25
$390.4M
$599.0M
Q1 25
$526.7M
$547.0M
Q4 24
$675.0M
Q3 24
$695.5M
$763.0M
Q2 24
$506.6M
$704.0M
Q1 24
$396.1M
$575.0M
Total Debt
ICLR
ICLR
OGN
OGN
Q4 25
$8.6B
Q3 25
$8.8B
Q2 25
$8.9B
Q1 25
$9.0B
Q4 24
$8.9B
Q3 24
$8.7B
Q2 24
$8.7B
Q1 24
$8.7B
Stockholders' Equity
ICLR
ICLR
OGN
OGN
Q4 25
$752.0M
Q3 25
$9.3B
$906.0M
Q2 25
$9.6B
$733.0M
Q1 25
$9.5B
$542.0M
Q4 24
$472.0M
Q3 24
$9.8B
$493.0M
Q2 24
$9.6B
$144.0M
Q1 24
$9.4B
$48.0M
Total Assets
ICLR
ICLR
OGN
OGN
Q4 25
$12.9B
Q3 25
$16.5B
$13.6B
Q2 25
$16.6B
$13.5B
Q1 25
$16.7B
$13.2B
Q4 24
$13.1B
Q3 24
$17.2B
$12.8B
Q2 24
$17.0B
$12.2B
Q1 24
$17.0B
$11.9B
Debt / Equity
ICLR
ICLR
OGN
OGN
Q4 25
11.49×
Q3 25
9.74×
Q2 25
12.14×
Q1 25
16.52×
Q4 24
18.81×
Q3 24
17.75×
Q2 24
60.11×
Q1 24
181.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICLR
ICLR
OGN
OGN
Operating Cash FlowLast quarter
$387.6M
$141.0M
Free Cash FlowOCF − Capex
$333.9M
$96.0M
FCF MarginFCF / Revenue
16.3%
6.4%
Capex IntensityCapex / Revenue
2.6%
3.0%
Cash ConversionOCF / Net Profit
164.59×
TTM Free Cash FlowTrailing 4 quarters
$1.0B
$538.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICLR
ICLR
OGN
OGN
Q4 25
$141.0M
Q3 25
$387.6M
$264.0M
Q2 25
$146.2M
$220.0M
Q1 25
$268.2M
$75.0M
Q4 24
$390.0M
Q3 24
$402.7M
$141.0M
Q2 24
$218.6M
$332.0M
Q1 24
$327.1M
$76.0M
Free Cash Flow
ICLR
ICLR
OGN
OGN
Q4 25
$96.0M
Q3 25
$333.9M
$218.0M
Q2 25
$113.9M
$181.0M
Q1 25
$239.3M
$43.0M
Q4 24
$335.0M
Q3 24
$359.3M
$99.0M
Q2 24
$182.3M
$300.0M
Q1 24
$299.9M
$30.0M
FCF Margin
ICLR
ICLR
OGN
OGN
Q4 25
6.4%
Q3 25
16.3%
13.6%
Q2 25
5.6%
11.4%
Q1 25
12.0%
2.8%
Q4 24
21.0%
Q3 24
17.7%
6.3%
Q2 24
8.6%
18.7%
Q1 24
14.3%
1.8%
Capex Intensity
ICLR
ICLR
OGN
OGN
Q4 25
3.0%
Q3 25
2.6%
2.9%
Q2 25
1.6%
2.4%
Q1 25
1.4%
2.1%
Q4 24
3.5%
Q3 24
2.1%
2.7%
Q2 24
1.7%
2.0%
Q1 24
1.3%
2.8%
Cash Conversion
ICLR
ICLR
OGN
OGN
Q4 25
Q3 25
164.59×
1.65×
Q2 25
0.80×
1.52×
Q1 25
1.74×
0.86×
Q4 24
3.58×
Q3 24
2.04×
0.39×
Q2 24
1.49×
1.70×
Q1 24
1.74×
0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ICLR
ICLR

Other Customers$681.3M33%
Clients1125$549.4M27%
Clients15$503.3M25%
Clients610$308.8M15%

OGN
OGN

Segment breakdown not available.

Related Comparisons